Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Arizona

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90032

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90095

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

View More ▼

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

UPDATED

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Rosa California 95403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

District of Columbia

UPDATED

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Florida

UPDATED

Miami Florida 33136

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Sarasota Florida 34232

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Sarasota Florida 34239

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Tampa Florida 33612

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Tampa Florida 33607

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

View More ▼

UPDATED

Weston Florida 33331

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Georgia

UPDATED

Athens Georgia 30607

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Augusta Georgia 30912

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Newnan Georgia 30265

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Hawaii

UPDATED

Honolulu Hawaii 96813

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Illinois

UPDATED

Chicago Illinois 60611

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Chicago Illinois 60629

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Hinsdale Illinois 60521

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Park Ridge Illinois 60068

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Zion Illinois 60099

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Indiana

UPDATED

Indianapolis Indiana 46202

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

New Albany Indiana 47150

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Kentucky

UPDATED

Louisville Kentucky 40241

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Louisiana

UPDATED

Baton Rouge Louisiana 70809

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

New Orleans Louisiana 70121

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Maryland

UPDATED

Silver Spring Maryland 20902

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Massachusetts

UPDATED

Boston Massachusetts MA 02215

A clinical research study of APR-246, Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD) for the treatment of Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

UPDATED

Boston Massachusetts MA 02114

A clinical research study of APR-246, Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD) for the treatment of Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

UPDATED

Boston Massachusetts 02114

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Boston Massachusetts 02114

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

UPDATED

Boston Massachusetts 02111

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

View More ▼

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

UPDATED

Worcester Massachusetts 01605

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Michigan

UPDATED

Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors